Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
Multilevel data compression using a single compression engine
Channel diagnostic system for sent receiver
Protocol and method of VIA field compression in session initiation protocol signaling for 3G wireless networks
Telephony usage derived presence information
Semiconductor wafer, light-receiving element, light-receiving element array, hybrid-type detection device, optical sensor device, and process for production of semiconductor wafer
Hand warmer
  Randomly Featured Patents
Corrugation apparatus
Noise reduction kit for can closing machine
Pagewidth printhead having sealed inkjet actuators
Output filter and method for on/off semi-active suspension control
Retroreflective dangles
Polypectomy instrument
Method and device for controlling a tool with ultrasonic waves
Methods and systems for recycling carpet and carpets manufactured from recycled material
Electric rotating machine
Adjustable rail barricade for working on a roof